Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginatechitosan microparticles Phenytoin loaded alginatechitosan microparticles

Drug Development and Industrial Pharmacy

Volumn 35, Issue 9, 2009, Pages 1092-1102

  Ceki, Neboja D ^a   Mili, Jela R ^b   Savi, Sneana D ^b   Savi, Miroslav M ^b   Jovi, Zarko ^c   Daniels, Rolf ^d  

^a DCP Hemigal ^*  (Serbia)

^b Faculty of Pharmacy   (Serbia)

^c Medicines and Medical Devices Agency of Serbia   (Serbia)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Alginate; Chitosan microparticles; Phenytoin; Physicochemical characterization; Preparation; Release behavior

Indexed keywords

ALGINIC ACID; CALCIUM ION; CHITOSAN; PHENYTOIN;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SYNTHESIS; MOLECULAR WEIGHT; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; THERMAL ANALYSIS;

ALGINATES; ANTICONVULSANTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG COMPOUNDING; EXCIPIENTS; GASTRIC EMPTYING; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PHENYTOIN;

EID: 70350672557     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902774164     Document Type: Article

References (38)

1. Donbrow M. (1992). Microcapsules and nanoparticles in medicine and pharmacy. New York: CRC Press, Inc., 2-14.
2. Tonessen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm, 28:621-630
3. Galeone M, Nizzola L, Cacioli D, Mosie G. (1981). In vitro demonstration of delivery mechanism from sustained release pellets. Curr Ther Res, 29:217-234
4. Coupe AJ, Davis SS, Wilding IR. (1991). Variation in gastrointestinal transit of pharmaceutical dosage form in healthy subject. Pharm Res, 18:360-364
5. Clarke GM, Newton JM, Short MD. (1993). Gastro intestinal transit of pellets of differing size and density. Int J Pharm, 10:81-92.
6. Fernandez-Hervas MJ, Holgado MA, Fini A, Fell JT. (1998). In vitro evaluation of alginate beads of diclofenac salt. Int J Pharm, 163:23-34.
7. Agnihotri SA, Aminabhavi TM. (2004). Formulation and valuation of novel tableted chitosan microparticles for the controlled release of clozapine. J Microencapsul, 21:709-718
8. Bechgaard H, Ladefoged K. (1978). Distribution of pellets in the gastro-intestinal tract. The influence on transit-time exerted by the density or diameter of pellets. J Pharm Pharmacol, 30:690-692
9. Gaserod O, Sannes A, Skjak-Braek G. (1999). Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability. Biomaterials, 20:773-783
10. McDowell RH. (1986). Properties of alginates, 5th ed. London: Kelco International.
11. Acarturk F, Takka S. (1999). Calcium alginate microparticles for oral administration. II. Effect of formulation factors on drug release and drug entrapment efficiency. J Microencapsul, 16:291-301. (Pubitemid 29191813)
12. Takka S, Acarturk F. (1999). Calcium alginate microparticles for oral administration: I. Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul, 16:275-290 (Pubitemid 29191812)
13. Mladenovska K, Raicki RS, Janevik EI, Ristoski T, Pavlova MJ, Kavrakovski Z, et al. (2007). Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles. Int J Pharm, 342:124-136
14. Murata Y, Nakada K, Miyamoto E, Kawashima S, Seo SH. (1993). Influence of erosion of calcium-induced alginate gel matrix on the release of brilliant blue. J Control Release. 23:21-26
15. Buthe A, Hartmeier W, Ansorge-Schumacher MB. (2004). Novel solvent-based method for preparation of alginate beads with improved roundness and predictable size. J Microencapsul, 21:865-876
16. Yotsuyanagi T, Yoshioka I, Segi N, Ikeda K. (1991). Acidinduced and calcium-induced gelation of alginic acid: Bead formation and pH dependent swelling. Chem Pharm Bull, 39:1072-1074
17. Gonzalez-Rodriguez ML, Holgado MA, Sanchez-Lafuente C, Rabasco AM, Fini A. (2002). Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm, 232:225-234
18. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2005). Papain entrapment in alginate beads for stability improvement and site-specific delivery: Physicochemical characterization and factorial optimization using neural network, modeling. AAPS PharmSciTech, 6:209-222
19. Roberts GAF. (1992). Chitin chemistry. Houndmills: Macmillan Press, 1-50.
20. Gaserod O, Smidsrod O, Skjak-Braek G. (1998). Microcapsules of alginate-chitosan. I. A quantitative study of the interaction between alginate and chitosan. Biomaterials, 19:1815-1825
21. Kas HS. (1997). Chitosan: Properties, preparation and application to microparticulate systems. J Microencapsul, 14:689-711.
22. Singla AK, Chawla M. (2001). Chitosan: Some pharmaceutical and biological aspects-an update. J Pharm Pharmacol, 53: 1047-1067
23. Kato Y, Onish H, Machida Y. (2003). Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol, l4:303-309
24. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. (2004). Chitosan microspheres as a potential carrier for drugs. Int J Pharm, 274:1-33.
25. Overgaard S, Scharer JM, Moo-Young M, Bols NC. (1991). Immobilization of hybridoma cells in chitosan alginate beads. Can J Chem Eng, 69:439-443
26. Huguet ML, Groboillot A, Neufeldt RJ, Poncelet D, Dellacherie E. (1994). Haemoglobin encapsulation in chitosan/calcium alginate beads. J Appl Polym Sci, 51:1427-1432
27. Huguet ML, Neufeld RJ, Dellacherie E. (1996). Calcium-alginate beads coated with polycationic polymers: Comparison of chitosan and DEAE-dextran. Process Biochem, 39:347-353
28. Lee KY, Park WH, Ha WS. (1997). Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives for microcapsules. J Appl Polym Sci, 63:425-432
29. Mladenovska K, Cruaud O, Richomme P, Belamie E, Raicki RS, Venier-Julienne MC. (2007b). 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int J Pharm, 345:59-69.
30. Lim F, Sun AM. (1980). Microencapsulated islets as bioartificial endocrine pancreas. Science, 210:908-910
31. Ceki N, Savi S, Mili J, Savi M, Jovi Ž, Maleševi M. (2007). Phenytoin-loaded alginate and alginate-chitosan microparticles: Preparation, encapsulation efficiency and release behaviour. Drug Delivery, 14:483-490
32. Pellock JM, Smith MC, Cloyd JC, Uthman B, Wilder BJ. (2004). Extended-release formulations: Simplifying strategies in the management of antiepileptic drug therapy. Epilepsy Behav, 5:301-307
33. Takahashi T, Takayama K, Machida Y, Nagai T. (1990). Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm, 61:35-41.
34. Polk A, Amsden B, De Yao K, Peng T, Goosena A. (1994). Calcium alginate matrices for oral multiple administration: IV. Release characteristics in different media. Int J Pharm, 112:241-248
35. Shu XZ, Zhu KJ. (2002). The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: The preparation method effect. Eur J Pharm Biopharm, 53:193-201.
36. Filipovic-Grcic J, Becirevic-Lacan M, Shalko N, Jalsenjak I. (1996). Chitosan microspheres of nifedipine and nifedipine- cyclodextrin inclusion complexes. Int J Pharm, 135:183-190
37. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2007). Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65: 215-232
38. Sezer AD, Akbuga J. (1999). Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. J Microencapsul, 16:195-203. (Pubitemid 29099601)